As expected in all cases, the embryos injected with the anti-Camel MO (camel morphants) developed hydrocephalus (Fig. 8a–d), whereas mRNA compensated this effect to a different degree in an indication of specificity of MO effect (Fig. 8f–h). The gene discussed is CTAG2; the disease is Hydrocephalus.